BELITE BIO INC - AMERICAN DEPOSITARY SHARES

Belite Bio Reports First-Quarter 2024 Financial Results and Provides Corporate Update

13 May 2024 20:50:29 By Nasdaq GlobeNewswire

Belite Bio to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference

13 May 2024 07:00:00 By Nasdaq GlobeNewswire

Belite Bio to Host Webcast on May 14, 2024, to Discuss First Quarter 2024 Financial Results

08 May 2024 07:00:00 By Nasdaq GlobeNewswire

Belite Bio to Participate in Key Opinion Leader Webinar to Discuss Unmet Needs In Stargardt Disease (STGD1) and Geographic Atrophy (GA) and Perspectives On Tinlarebant

06 May 2024 07:15:00 By Nasdaq GlobeNewswire

Belite Bio Presents Additional Analysis from Phase 2 Study of Tinlarebant in Stargardt Disease at the ARVO Annual Meeting

06 May 2024 07:00:00 By Nasdaq GlobeNewswire

Belite Bio Announces Presentation at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting

01 May 2024 15:15:00 By Nasdaq GlobeNewswire

Belite Bio Announces $25 Million Registered Direct Offering

25 Apr 2024 18:15:29 By Nasdaq GlobeNewswire

Belite Bio Announces PMDA Submission of Tinlarebant for Stargardt Disease Clinical Trial in Japan

22 Mar 2024 07:00:00 By Nasdaq GlobeNewswire

Belite Bio Announces Availability of Annual Report on Form 20-F Through Company Website

11 Mar 2024 21:28:39 By Nasdaq GlobeNewswire

Belite Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

11 Mar 2024 20:27:47 By Nasdaq GlobeNewswire

Belite Bio to Host Webcast on March 12, 2024, to Discuss Fourth Quarter and Full Year 2024 Financial Results

06 Mar 2024 07:00:01 By Nasdaq GlobeNewswire

Belite Bio to Participate in the Leerink Partners Global Biopharma Conference

04 Mar 2024 07:00:00 By Nasdaq GlobeNewswire

Belite Bio to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

07 Feb 2024 07:00:00 By Nasdaq GlobeNewswire

Belite Bio to Participate in the Benchmark Company’s Upcoming Discovery One-on-One Investor Conference

30 Nov 2023 07:00:00 By Nasdaq GlobeNewswire

Belite Bio to Participate in the BTIG Ophthalmology Day

20 Nov 2023 07:00:00 By Nasdaq GlobeNewswire

Belite Bio Reports Third Quarter 2023 Operational Highlights and Financial Results

13 Nov 2023 19:15:47 By Nasdaq GlobeNewswire

Belite Bio to Host Webcast on November 14, 2023, to Discuss Third Quarter 2023 Financial Results

07 Nov 2023 07:00:00 By Nasdaq GlobeNewswire

Belite Bio Presents Results from a 24-month, Phase 2 Study of Tinlarebant in Childhood-onset Stargardt Disease at the AAO Annual Meeting

06 Nov 2023 07:00:00 By Nasdaq GlobeNewswire

Belite Bio Announces Presentation at the American Academy of Ophthalmology 2023 Annual Meeting

27 Oct 2023 07:00:00 By Nasdaq GlobeNewswire

Belite Bio Reports Second Quarter 2023 Operational Highlights and Financial Results

08 Aug 2023 21:17:28 By Nasdaq GlobeNewswire